title: Non-intravenous approaches to iron therapy in chronic kidney disease: will it improve the benefit-to-risk ratio?
authors.forename: Anatole
authors.initials: A
authors.lastname: Besarab
mesh_terms: D000284:Administration, Oral; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects*; D019190:Iron Overload / Q000139:chemically induced* / Q000517:prevention & control; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D018570:Risk Assessment
chemical_list: D006397:Hematinics; D007501:Iron